What's been happening

From new centres and equipment to the latest in care, stay on top with what we are doing

GenesisCare and the University of Oxford establish innovative 10-year research partnership

7 February, 2019

GenesisCare and the University of Oxford establish innovative 10-year research partnership to improve diagnosis and care for people with cancer 10-year partnership established between the UK’s largest private provider of radiotherapy and world-leading university to drive cancer research and improve care services across the UK Major investment will bring advanced radiotherapy technology to the UK…

Read More

December 2018

20 December, 2018

Karthik Ramasamy MBBS, FRCP, FRCPath, PhD. GenesisCare’s new Clinical Director for Haematology Services

Karthik is a Consultant Haematologist at Oxford University Hospitals NHS Trust and GenesisCare’s new Clinical Director for haematology services. Karthik is also the Director of the Oxford Myeloma Translational Research Centre, the Lead Clinician for myeloma and other plasma cell dyscrasias at the Thames Valley Strategic Clinical Network, Divisional Lead for Cancer research for National…

November 2018

5 November, 2018

Innovative breast cancer treatment technique now available within Wide Bay for the first time

An innovative treatment technique for suitable left-sided breast cancer patients has officially launched in regional Queensland. The best practice technique called deep inspiration breath hold (DIBH) reduces the effects of radiotherapy on the heart to minimise the risk of long-term side effects. GenesisCare is now providing the service at its new radiation oncology centres co-located…

5 November, 2018

GenesisCare Continues Australian & International Expansion of New World Class Treatment Centres Supported by Major Capital Raising

Sydney-headquartered GenesisCare, the largest private provider of cancer and cardiac healthcare in Australia and Europe, announced today that it had completed a major capital raising, including a refinancing of debt facilities, while securing a second major investor. New funds raised will be directed towards GenesisCare’s core mission of improving patient access and raising the standard…

5 November, 2018

New $6.6 million comprehensive cancer centre to be built in Concord

New cancer centre in Concord announced, to respond to Canada Bay Local Government Area’s high priority need for a new radiotherapy service State-of-the-art facility to open mid-2019 and will be equipped to deliver up to 16,200 radiotherapy and chemotherapy treatments for up to 1,100 cancer patients annually GenesisCare has officially started construction on a comprehensive…

October 2018

31 October, 2018

Our new UK Clinical Director of Stereotactic Radiotherapy shares his insights into ‘SABR’

James is a consultant oncologist with a special interest in gastro-intestinal and head/neck cancers at the Queen Elizabeth Hospital, Birmingham. He has a particular focus on precision radiotherapy for liver/pancreas tumours and clinical trials. James recently joined GenesisCare as clinical director of stereotactic radiotherapy, and sees patients at GenesisCare Birmingham and GenesisCare Oxford. Here he…